About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in California | 676 Studies

Clinical Trials Pancreatic CancerCalifornia

Pancreatic Cancer Clinical Trials in California

Find 676 clinical trials for pancreatic cancer near California. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 201-220 of 676 trials

CompletedB-Receptor Signaling in CardiomyopathyWe hope to determine the importance of different genes (including B receptors) in anthracycline-induced cardiomyopathy.NCT01135849·Stanford, California TerminatedCMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except MelanomaThis phase Ib/II trial studies the side effects and best dose of CMP-001 and how well it works when given together with INCAGN01949 in treating patients with stage IV pancreatic…NCT04387071·Scottsdale, Arizona and 3 others CompletedFeasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic CancerThis is a prospective, single center, double blind, randomized, crossover feasibility study of oral ketamine versus placebo for the treatment of anxiety in patients with…NCT05086250·Los Angeles, California

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingStereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized ApproachThis trial is a single-arm, prospective, multi-center clinical trial designed to demonstrate that stereotactic adaptive radiotherapy using an ablatively dosed (50Gy,5fx) for…NCT05764720·Birmingham, Alabama and 3 others

CompletedRegorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine TumorsThis phase II trial studies regorafenib in treating patients with neuroendocrine tumors that have spread from the primary site (place where it started) to other places in the body.NCT02259725·Scottsdale, Arizona and 4 others

CompletedImproving Pancreas Radiotherapy Plans Using Respiration-driven Anatomic Deformation: A Pilot StudyThe overall aim of this study is to investigate a novel "dual instance" planning method to make use of the respiratory motion to improve pancreatic radiation therapy (RT)…NCT02024997·Los Angeles, California

TerminatedPhase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic CancerGTI-4711-201 is designed as a Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to determine the effect to OS by adding GC4711 to SBRT following…NCT04698915·Gilbert, Arizona and 34 others

RecruitingA Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsThis study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, pancreatic cancer, and other specific solid…NCT07488676·Birmingham, Alabama and 20 others

RecruitingGenetic Predisposition Testing Program for Pancreatic Neuroendocrine NeoplasmsThis is a prospective observational multi-center pilot study of germline testing for participants receiving care at University of California participating locations with a new or…NCT05746182·Los Angeles, California and 2 others

Completed18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyThe purpose of the study is to conduct research of a new PET radiopharmaceutical in cancer patients.NCT01806675·Stanford, California

CompletedARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic CancerThe study will document the safety and efficacy of the combination of ARQ 501 and gemcitabine in patients with treatment-naïve, unresectable, metastatic pancreatic adenocarcinoma.NCT00102700·Mobile, Alabama and 14 others

TerminatedChemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic CancerThe current trial will provide important data on the recurrence rates and patterns of failure using state of the art target agent, chemotherapy and proton beam technology for…NCT01683422·Loma Linda, California

CompletedA Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic CancerThe study consists of a Phase1b lead-in portion to determine the maximum tolerated dose (MTD) of OMP-59R5 in combination with nab-paclitaxel and gemcitabine followed by a Phase 2…NCT01647828·Goodyear, Arizona and 25 others

CompletedSafety Study of ²¹²Pb-TCMC-Trastuzumab Radio ImmunotherapyMonoclonal antibodies can transport and deliver radioactive elements capable of releasing sufficient amounts of energy to destroy tumor cells.NCT01384253·Birmingham, Alabama and 1 other

WithdrawnKetamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck CancersThe primary purpose of this study is to see if it is safe to give patients with pancreatic or head and neck cancer a low dose of the FDA approved anesthetic drug ketamine at the…NCT02442739·Los Angeles, California

RecruitingA Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic AlterationsThis phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread from where it first started to nearby tissue…NCT06906562·Birmingham, Alabama and 108 others

RecruitingThe Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic CancerThe aim of this Phase 3 study is to evaluate the efficacy of Kinisoquin™ as compared to the placebo in prevention of thromboembolic events in patients with metastatic or locally…NCT06861088·Ventura, California and 2 others

CompletedStudy of [18F]FAPI-74 PET in Patients With Gastrointestinal CancersProspective, multi-center, open label, non-randomized clinical trial to assess efficacy of \[18F\]FAPI-74 to detect FAP expressing cells in patients diagnosed with…NCT05641896·Los Angeles, California and 5 others

CompletedComparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable DuodenoscopeThe purpose of the study is to compare the success rates of procedure success and complication rates in patients undergoing Endoscopic retrograde cholangiopancreatography (ERCP)…NCT05429203·Palo Alto, California

RecruitingStudy of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA TherapyThis study aims to determine the safety, pharmacokinetics (PK) and recommended Phase 3 dose (RP3D) of RYZ101 in Part 1, and the safety, efficacy, and PK of RYZ101 compared with…NCT05477576·Phoenix, Arizona and 53 others

PreviousPage 11 of 34Next

Other Conditions in California

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia